Manchester Science Partnerships (MSP) has today revealed plans for the first phase of development at their 400-acre life science campus at Alderley Park.
The plans centred on the Mereside science campus and were revealed at MIPIM - the annual international property conference held in Cannes, France.
The plans signal the first major step for MSP's vision to transform Alderley Park, AstraZeneca's former R&D headquarters, into a thriving open innovation community for life science businesses, with over 7,000 high-value jobs planned on-site in the next decade.
Bruntwood and MSP have committed to £30 million capital investment for the next three years at Alderley Park to deliver 1.5m sq ft lettable lab and workspace, to respond to the demand and needs of a multi-occupier site, which already features state-of-the-art laboratory and office workspace.
The initial Mereside designs were revealed whilst the site-wide redevelopment plans for Alderley Park are currently subject to a public consultation process, as part of the Cheshire East Council strategic development Masterplan, which is a draft framework to set the guidance for future development.
One of the first major redevelopments for MSP and Bruntwood, is the redesign of a four-story building on the Eastern edge of Mereside, transforming an old AstraZeneca lab facility into a 300,000 sq ft business centre which will include a variety of workspaces from high-end specialist labs to flexible offices and manufacturing facilities.
Designs will centre around a new communal atrium and internal courtyard featuring new meeting and conference facilities with views over the Alderley Park woodland. In addition, substantial new entrances will open up the building and the plans will also feature opportunities for retail and café facilities.
Rowena Burns, CEO Manchester Science Partnerships comments: "Our bold scheme for this once forgotten building demonstrates the sheer scale of the opportunity at Alderley Park. With 300,000 sq ft of additional space, we are taking the first major step toward expanding the business community here, and fulfilling our commitment to provide 7,000 high-value jobs within the next ten years."
Councillor Michael Jones, Leader of Cheshire East Council said: "We hope that, with the right strategic planning framework in place, we can create a unique, self-sustaining hub for the life science sector at Alderley Park.
"That is why, alongside AstraZeneca and Manchester Science Partnerships, Cheshire East Council has committed to invest £5m in a new investment fund to support the development of established companies on the site. Alderley Park represents an exciting opportunity that is vitally important to our economy and to the strength and growth of the life sciences industry in the North West as a whole."
Comments
Here's what readers have had to say so far. Why not add your thoughts below.
So how many houses and cars is that within driving distance then !
Comment and web link by Mr Taylor...... ( stay with it ) makes interesting reading.
Cllrs, please stop buying into the private sector and that includes land. Leave private enterprise alone. You add no value, you cannot, with no understanding. Stop it!
CEC should not be involved in any private sector initiatives other than at UK Government strategic level. The development of a redundant science park other than its major UK science input i.e Daylesbury, is not the responsibility of the Council.
CEC just seem to appear to have jumped onto the the commercial/private development market, and all the risks, just to make a quick buck.
Socialism by the back door.
Once the greedy council of Manchester got involved it was clear that making money was the plan all round. Our business amateurs at Cheshire East will be fully utilised in that process.
If this is such a viable site why was the news that Astra Zeneca were deserting the area taken so badly? What don't we know?